Document resource
Switching to an oral treatment may reduce the weight gain commonly seen when patients stop treatment with injectable glucagon-like peptide-1 (GLP-1) receptor agonists, a study has found.
Annotated abstract
GLP-1: Daily pill reduces weight rebound after stopping injections, study suggests
bmj · 2026-05-13 · canonical JSON source